Continuous Glucose Monitoring and Diabetes

Stopped early · Not applicable

Conditions studied: Diabetes

In brief

The study is a longitudinal single-arm prospective study design. Adult patients who are African American or Hispanic with type 2 diabetes mellitus will be recruited to participate in this study. The goal of the study is to determine if the use of a continuous glucose monitoring system will improve diabetes management in persons from health disparity background. The subjects will be closely monitored for the first 3 months as they utilize the continuous glucose monitor and engage in diabetes education classes. They will then be followed for an additional 3 months to determine if they are able to maintain the same glucose control as experienced for the initial 3 months.

Key facts

Study ID

NCT05840250

Run by

Hackensack Meridian Health

People needed

10

Starts

2023-05-15

Expected to finish

2024-09-14

Last updated by the study team

2025-01-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult subjects with type 2 diabetes mellitus ≥18 years
• African-American or Hispanic
• with A1c ≥8% to ≤12%

You may not qualify if…

• Patients with type 1 diabetes,
• pregnant,
• End-Stage Renal Disease,
• recent use of any CGM within the last 12 months,
• on steroid therapy and history of adhesive allergy.

Where it is running

• Hackensack Univeristy Medical Center — Hackensack, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.